1. Home
  2. SAVA vs AMTX Comparison

SAVA vs AMTX Comparison

Compare SAVA & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$2.13

Market Cap

96.1M

Sector

Health Care

ML Signal

HOLD

Logo Aemetis Inc. (DE)

AMTX

Aemetis Inc. (DE)

HOLD

Current Price

$1.53

Market Cap

98.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAVA
AMTX
Founded
1998
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
96.1M
98.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SAVA
AMTX
Price
$2.13
$1.53
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$5.00
$17.00
AVG Volume (30 Days)
772.9K
1.1M
Earning Date
03-02-2026
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$201,323,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$139.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.15
$1.22
52 Week High
$4.98
$3.66

Technical Indicators

Market Signals
Indicator
SAVA
AMTX
Relative Strength Index (RSI) 47.99 42.29
Support Level $2.04 $1.50
Resistance Level $2.22 $1.57
Average True Range (ATR) 0.11 0.14
MACD 0.03 -0.02
Stochastic Oscillator 62.86 2.04

Price Performance

Historical Comparison
SAVA
AMTX

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.

Share on Social Networks: